Study of SCY-078 in patients with in patients with refractory invasive fungal infections

Trial Profile

Study of SCY-078 in patients with in patients with refractory invasive fungal infections

Planning
Phase of Trial: Phase II

Latest Information Update: 10 Aug 2016

At a glance

  • Drugs SCY 078 (Primary) ; SCY 078 (Primary)
  • Indications Mycoses
  • Focus Therapeutic Use
  • Most Recent Events

    • 10 Aug 2016 New trial record
    • 01 Aug 2016 According to Scynexis media release, this trial is expected to start by the end of 2016.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top